none28noPostoperative outcomes of 3rd generation porcine bioprosthesis for mitral valve replacement (MVR) have been poorly addressed. The objective of this study was to perform an independent, retrospective, multicenter study on outcomes of patients undergoing MVR with Mosaic (Medtronic Inc., Minneapolis, MN) porcine bioposthesis.noneLorusso, Roberto; Miceli, Antonio; Gelsomino, Sandro; Lio, Antonio; Parise, Orlando; Montisci, Andrea; Vizzardi, Enrico; Pacini, Davide; Di Bartolomeo, Roberto; Renzulli, Attilio; Serraino, Filiberto G; Comoglio, Chiara; Liberi, Roberta; Martinelli, GianLuca; Sciangula, Alfonso; Mazzola, Alessandro; Faragalli, Francesca; De Bonis, Michele; Taramasso, Maurizio; Alfieri, Ottavio; Caimmi, Philippe; Micalizzi, Ezio...
The current status of valve replacement was reviewed by analyzing six groups of 100 consecutive pati...
AbstractBackground: Bioprostheses preserved with glutaraldehyde, both porcine and pericardial, have ...
Background: The aim was to assess the incidence of prosthesis-patient mismatch (PPM) after mitral va...
none28noPostoperative outcomes of 3rd generation porcine bioprosthesis for mitral valve replacement ...
BACKGROUND Postoperative outcomes of 3$^{rd}$ generation porcine bioprosthesis for mitral valve rep...
Background. Postoperative outcomes of a third-generation porcine bioprosthesis for mitral valve repl...
Background: We analyzed the intermediate experience, survival, and prosthetic complications of patie...
BackgroundWe analyzed the intermediate experience, survival, and prosthetic complications of patient...
lumb d form n to e of p jecti subset of non-reparable or failed repair patients by using the knowled...
We reviewed the cases of 100 patients (mean age, 73 ± 10 yr; 64 men) who had mitral valve replacemen...
Objective: Performance of the prostheses must be verified in the time domain. We report the 20-year ...
BackgroundThe Mosaic porcine bioprosthesis (Medtronic, Inc, Minneapolis, Minn) was approved in 2000 ...
We reviewed the cases of 100 patients (mean age, 73 +/- 10 yr; 64 men) who had mitral valve replacem...
AbstractObjective: The purpose of this study was to prospectively evaluate the clinical and hemodyna...
Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR) for patien...
The current status of valve replacement was reviewed by analyzing six groups of 100 consecutive pati...
AbstractBackground: Bioprostheses preserved with glutaraldehyde, both porcine and pericardial, have ...
Background: The aim was to assess the incidence of prosthesis-patient mismatch (PPM) after mitral va...
none28noPostoperative outcomes of 3rd generation porcine bioprosthesis for mitral valve replacement ...
BACKGROUND Postoperative outcomes of 3$^{rd}$ generation porcine bioprosthesis for mitral valve rep...
Background. Postoperative outcomes of a third-generation porcine bioprosthesis for mitral valve repl...
Background: We analyzed the intermediate experience, survival, and prosthetic complications of patie...
BackgroundWe analyzed the intermediate experience, survival, and prosthetic complications of patient...
lumb d form n to e of p jecti subset of non-reparable or failed repair patients by using the knowled...
We reviewed the cases of 100 patients (mean age, 73 ± 10 yr; 64 men) who had mitral valve replacemen...
Objective: Performance of the prostheses must be verified in the time domain. We report the 20-year ...
BackgroundThe Mosaic porcine bioprosthesis (Medtronic, Inc, Minneapolis, Minn) was approved in 2000 ...
We reviewed the cases of 100 patients (mean age, 73 +/- 10 yr; 64 men) who had mitral valve replacem...
AbstractObjective: The purpose of this study was to prospectively evaluate the clinical and hemodyna...
Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR) for patien...
The current status of valve replacement was reviewed by analyzing six groups of 100 consecutive pati...
AbstractBackground: Bioprostheses preserved with glutaraldehyde, both porcine and pericardial, have ...
Background: The aim was to assess the incidence of prosthesis-patient mismatch (PPM) after mitral va...